Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, announced they are joining forces to develop a comprehensive ecosystem for early cancer detection, cancer risk prediction and independent AI to improve clinical workflows.
In May, Lunit acquired Volpara...
Editor's note: This article has been updated with a comment from the NIH.
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer-treatment drugs using individual tumor cells, according to a study published in Nature Cancer.
Traditional approaches to...
GE HealthCare announced a strategic partnership with Mayo Clinic dubbed the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, through which the pair will collaborate on research and product development focusing on precision care, AI and theranostics.
Technology developers, clinicians, scientists and other providers from both companies will work together to advance...
LifeSemantics teases pulmonary rehabilitation DTx
South Korean digital health company LifeSemantics is launching its digital therapeutics product that helps with the pulmonary rehabilitation of people with COPD.
The Redpill Breath DTx helps users self-rehabilitate their respiratory functions at home. It monitors their oxygen saturation and walking performance in real time, sends text alerts in...
